Mark Bryer MD has Radiation Oncology as his primary medical specialty. Their primary office is: 54 Hospital Dr in Osage Beach, Missouri.
There is an additional office location, for a total of two, for Mark Bryer MD that can be viewed further down.
They're a part of the: Missouri Cancer Care Pharmacy medical group which has around 24 members. You can call their office at 573-302-2772 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Perelman School Of Med At The University Of Pennsylvania and graduated in 1986 (around 38 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.
Mark Bryer MD
Missouri Cancer Care Pharmacy
54 Hospital Dr
Osage Beach, Missouri 65065
573-302-2772
Phone: 573-302-2772
Enter a starting address:
Medical School: Perelman School Of Med At The University Of Pennsylvania
Graduation Year: 1986
The Primary Medical Specialty for Mark Bryer MD is listed as: Radiation Oncology
Credentials: MD
Additional Credentials:
Approximate Years of Experience: 38
PAC (PECOS ID)#: 2668570425
NPI #: 1144217324
NPI Created On: 10/03/2005
NPI Last Updated Listed as: 10/05/2022
Primary Taxonomy Code: 2085R0001X
License Number:
102993
Listed Gender: Male
Forms of insurance accepted by include, but are not limited to:
They are listed as accepting new patients.
Languages spoken by staff include: English.
Services and Procedures include:
Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787918503
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Drug or Biological: Biological
Product Category #2: Oncology
Name Of Drug #2:: IMBRUVICA
Associated Drug #2: 57962-140-09
Payments Total: $13
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787918505
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Payments Total: $11
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787918507
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Payments Total: $11
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787918509
Being Disputed:: No
Product Related: Yes
Drug or Biological: Biological
Product Category #1: Oncology
Name of Drug #1: DARZALEX
Open Associated Drug #1: 57894-502-05
Drug or Biological: Biological
Product Category #2: Oncology
Name Of Drug #2:: IMBRUVICA
Associated Drug #2: 57962-140-09
Payments Total: $20
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787918511
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $18
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787918513
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $13
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787918515
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Payments Total: $19
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787918517
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: IMBRUVICA
Open Associated Drug #1: 57962-140-09
Drug or Biological: Drug
Product Category #2: Oncology
Name Of Drug #2:: DARZALEX
Associated Drug #2: 57894-502-05
Payments Total: $11
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787918519
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
Payments Total: $14
Number of Payments:: 1
Form of Payment: In-kind items and services
Third party is a Charity:: No
Record ID:: 787918521
Being Disputed:: No
Product Related: Yes
Drug or Biological: Drug
Product Category #1: Oncology
Name of Drug #1: ERLEADA
Open Associated Drug #1: 59676-600-12
1. Missouri Cancer Care Pharmacy
1705 E Broadway
Columbia, MO 65201
Suite 100
Group Members: 24
Phone: 573-302-2772
Enter a starting address:
1705 E Broadway
Columbia Mo 65201-7167
Missouri Cancer Care Pharmacy
Radiation Oncology
601 E 14th St
Sedalia Mo 65301-5972
Missouri Cancer Care Pharmacy
Radiation Oncology
603 W Pierce St
Kirksville Mo 63501-1448
Missouri Cancer Care Pharmacy
Hematology/oncology
1705 E Broadway
Columbia Mo 65201-7167
Missouri Cancer Care Pharmacy
Hematology/oncology
603 W Pierce St
Kirksville Mo 63501-1448
Missouri Cancer Care Pharmacy
Radiation Oncology
1705 E Broadway
Columbia Mo 65201-7167
Missouri Cancer Care Pharmacy
Radiation Oncology
View all 24 members of Missouri Cancer Care Pharmacy medical group